Might be another question to ask at the AGM. Why has there not been any update, stated progress, or products commercialised regarding Starpharma’s collaboration with Lilly’s animal health division after 13 years!!
After all as you have stated on this forum previously @antibotter, if Jackie Fairley and SPL have not specifically retracted a development or partnership in an update to the ASX, it must still be on foot.
IMO probably just another one of those developments that just tend to drift off into the ether and disappear with adequate explanation.
Might be another question to ask at the AGM. Why has there not...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
0.001(1.03%) |
Mkt cap ! $40.97M | |||
| Open | High | Low | Value | Volume |
| 9.7¢ | 9.9¢ | 9.7¢ | $44.76K | 455.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 824859 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 121525 | 5 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |